2023 annual financial data
Coherus Oncology 2023 Net margin
Direct answer
Net margin was -92.48%.
Operating income was -203,199,000 USD and net income was -237,892,000 USD.
Operating cash flow was -174,884,000 USD.
Get free Coherus Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 257,244,000 USD
- Operating income
- -203,199,000 USD
- Net income
- -237,892,000 USD
- Operating cash flow
- -174,884,000 USD